Company Profile | February 27, 2014

2014 CRO Leadership Awards Winner

basi logo

Categories Won:

  1. Reliability

  2. Regulatory

 

Drug Life Cycle Stages:

  • Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)
  • Formulated Drug Production: Dosage Form Development

Main Service Areas:
Bioanalytical, Clinical, Preclinical

Services & Capabilities:
Culex® In Vivo Drug  Discovery (ADME, neuroscience), preclinical toxicology (GLP/non-GLP), bioanalytical (method development, validation, and sample analysis), and pharmaceutical analysis (in  vitro bioequivalence, electrochemical detection, dose formulation analysis)

Therapeutic Areas:
Diabetes, infectious disease, biomarkers, pain, cardiology, gastrointestinal, neurology/CNS, oncology, steroids, drug-coated medical devices

Jacqueline M. Lemke

president and CEO

“We are pleased to be recognized as leaders in our industry for our regulatory compliance and reliability. Our clients expect this level of excellence, and we are happy to deliver it. This year we celebrate our 40th anniversary and look forward to continued success with our partners in pharma, biotech, and the regulatory agencies. Regulatory excellence, along with innovation and customer service, are our top priorities.”